Epigenetic signals in blood detected up to 8 years before cancer diagnosis

A study reports epigenetic changes in blood samples collected years before prostate or breast cancer diagnosis, suggesting potential early detection markers. The biological meaning of these signals remains unclear, and validation in larger cohorts is pending. If confirmed, this could enable earlier intervention, but current findings are preliminary.